However, these subjective findings are contradicted by EEG analyses, which in contrast revealed no apparent sedation in the classic pharmacologic way
The more recent REDUCE-IT trial (n = 8,179) found that 4 g/day of icosapent ethyl (a purified eicosapentaenoic acid ethyl ester) significantly reduced cardiovascular death (HR 0.75, 95% CI 0.680.83), myocardial infarction, and stroke in high-risk individuals with elevated triglycerides despite statin therapy
Is this an addiction akin to alcoholism
This can lead to build-up of toxins in the liver and other organs, damage to cells requiring more cellular repair, and the inability of energy production
Researchers noted that more clinical trials are needed to know whether the findings also apply to people without obesity
They presented an abstract at ENDO 2025 titled, One-Year Real-World Weight Loss Outcomes with Tirzepatide in Postmenopausal Women With and Without Hormone Therapy. Join our endocrine community and become a member